Net Income for AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's current net income (TTM) is $4.23B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
ABBV
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$4.23B
YoY change
-1.2%
5Y CAGR
-1.7%
Peak year (2022)
$11.84B
Cumulative net income
$94.76B
Net Income history chart for AbbVie (ABBV) from 2009 to 2025
Net Income history table for AbbVie (ABBV) from 2009 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $4.23B | -1.2% | ||
| 2024 | $4.28B | -12.0% | ||
| 2023 | $4.86B | -58.9% | ||
| 2022 | $11.84B | +2.5% | ||
| 2021 | $11.54B | +150.0% | ||
| 2020 | $4.62B | -41.4% | ||
| 2019 | $7.88B | +38.6% | ||
| 2018 | $5.69B | +7.1% | ||
| 2017 | $5.31B | -10.8% | ||
| 2016 | $5.95B | +15.7% | ||
| 2015 | $5.14B | +190.0% | ||
| 2014 | $1.77B | -57.0% | ||
| 2013 | $4.13B | -21.7% | ||
| 2012 | $5.28B | +53.7% | ||
| 2011 | $3.43B | -17.8% | ||
| 2010 | $4.18B | -9.9% | ||
| 2009 | $4.64B | — |
Net Income values are taken from AbbVie's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
AbbVie (ABBV) most recent annual net income stands at $4.23B (2025) – edged down 1.2% year-over-year.
Through 2020–2025 (5 years), AbbVie net income delivered a -1.7% annualised rate; with a net decline across the window.
AbbVie net income peaked at $11.84B in 2022; the latest annual figure is $4.23B in 2025 (64.3% below peak).
$11.84B stands as the all-time-high annual net income, posted in 2022, against a low of $1.77B during 2014.
AbbVie (ABBV) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $15.15B.
AbbVie Net Income by Year
AbbVie Net Income 2025: $4.23B
AbbVie net income in 2025 was $4.23B, edged down 1.2% below 2024.
AbbVie Net Income 2024: $4.28B
AbbVie net income in 2024 was $4.28B, declined 12.0% below 2023.
AbbVie Net Income 2023: $4.86B
AbbVie net income in 2023 was $4.86B, plunged 58.9% below 2022.
AbbVie Net Income 2022: $11.84B
AbbVie net income in 2022 was $11.84B, edged up 2.5% from 2021. This figure represents the highest annual value in the available history.
AbbVie Net Income 2021: $11.54B
AbbVie net income in 2021 was $11.54B.
See more financial history for AbbVie (ABBV).
Sector peers — Net Income
Companies in the same sector as AbbVie, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $6.74B | Healthcare |
Frequently asked questions
What is AbbVie's net income?
- Latest reported net income for AbbVie (ABBV) is $4.23B (period ending December 31, 2025).
How has AbbVie net income changed year-over-year?
- AbbVie (ABBV) net income changed -1.2% year-over-year on the latest annual filing.
What is the long-term growth rate of AbbVie net income?
- AbbVie (ABBV) net income compound annual growth rate is -1.7% over the most recent 5 years available.
When did AbbVie net income hit its highest annual value?
- AbbVie net income reached its highest annual value of $11.84B in 2022.
What was AbbVie net income in 2024?
- AbbVie (ABBV) net income in 2024 was $4.28B.
What was AbbVie net income in 2025?
- AbbVie (ABBV) net income in 2025 was $4.23B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABBV Overview
Company profile, financial tools, and key metrics
ABBV Revenue Counter
Earns $1,939 every second. See per minute, hour, and day.
ABBV Earnings Counter
Earns $134.01 per second net profit. See per minute, hour, and day.
ABBV Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
ABBV What If Invested
What if you had invested $1,000? See historical returns from any date.
ABBV How It Makes Money
Discover visual breakdown of $61.16B in revenue — where it comes from and where it goes.
ABBV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABBV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABBV Daily Price Character
Steady · 53.5% historical win rate (green days). Streaks & record days.
ABBV Buybacks
0.24% TTM buyback yield. Shareholder yield & SBC comparison.
ABBV Dividend Profile
Yield: 3.31%. Safety: 6/8. See full history.
ABBV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABBV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.